Induction of superficial zone protein (SZP)/lubricin/PRG 4 in muscle-derived mesenchymal stem/progenitor cells by transforming growth factor-β1 and bone morphogenetic protein-7

Arthritis Research and Therapy

Volumn 14, Issue 2, 2012, Pages

  Andrades, José A ^a   Motaung, Shirley C ^b   Jiménez Palomo, Pedro ^a   Claros, Silvia ^a   López Puerta, José M ^c   Becerra, José ^a   Schmid, Thomas M ^d   Reddi, A Hari ^a,e  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b TSHWANE UNIVERSITY OF TECHNOLOGY   (South Africa)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; CD34 ANTIGEN; CD45 ANTIGEN; LUBRICIN; MESSENGER RNA; OSTEOGENIC PROTEIN 1; PRG 4 PROTEIN; PROTEIN; RNA; STRO 1 PROTEIN; SUPERFICIAL ZONE PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; GLYCOPROTEIN; PRG4 PROTEIN, HUMAN; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SKELETAL MUSCLE; TISSUE CULTURE; ANIMAL; ARTICULAR CARTILAGE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; FEMALE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; STEM CELL; WISTAR RAT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GLYCOPROTEINS; MESENCHYMAL STROMAL CELLS; MUSCLE, SKELETAL; PROTEOGLYCANS; RATS; RATS, WISTAR; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84859504479     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3793     Document Type: Article

References (16)

1. Karlsson C, Lindahl A. Articular cartilage stem cell signaling. Arthritis Res Ther 2009, 11:121-122. 10.1186/ar2753, 2745782, 19664192.
2. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331:889-895. 10.1056/NEJM199410063311401, 8078550.
3. Kuroda R, Ishida K, Matsumoto T, Akisue T, Fujoka H, Mizuno K, Ohgushi H, Wakitani S, Kurosaka M. Treatment of full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 2007, 15:226-231. 10.1016/j.joca.2006.08.008, 17002893.
4. Funakoshi T, Martin SD, Wolf BT, Schmid TM, Thornhill TS, Spector M. Alpha-smooth muscle actin-expressing cells and lubricin in periprosthetic tissue. J Biomed Mater Res A 2010, 93:515-527.
5. Claros S, Alonso M, Becerra J, Andrades JA. Selection and induction of rat skeletal muscle-derived cells to the chondro-osteogenic lineage. Cell Mol Biol 2008, 54:1-10.
6. Yamane S, Reddi AH. Induction of chondrogenesis and superficial zone protein accumulation in synovial side population cells by BMP-7 and TGF-beta1. J Orthop Res 2008, 26:485-492. 10.1002/jor.20521, 17972329.
7. Niikura T, Reddi AH. Differential regulation of lubricin/superficial zone protein by transforming growth factor beta/bone morphogenetic protein superfamily members in articular chondrocytes and synoviocytes. Arthritis Rheum 2007, 56:2312-2321. 10.1002/art.22659, 17599751.
8. Lee SY, Nakagawa T, Reddi AH. Induction of chondrogenesis and expression of superficial zone protein (SZP)/lubricin by mesenchymal progenitors in the infrapatellar fat pad of the knee joint treated with TGF-beta1 and BMP-7. Biochem Biophys Res Comm 2008, 376:148-153. 10.1016/j.bbrc.2008.08.138, 18774772.
9. Musumeci G, Lo Furno D, Loreto C, Giuffrida R, Caggia S, Leonardi R, Cardile V. Mesenchymal stem cells from adipose tissue which have been differentiated into chondrocytes in three-dimensional culture express lubricin. Exp Biol Med 2011, 236:1333-1341.
10. Kupcsik L, Stoddart MJ, Li Z, Benneker LM, Alini M. Improving chondrogenesis: potential and limitations of SOX9 gene transfer and mechanical stimulation for cartilage tissue engineering. Tissue Eng Part A 2010, 16:1845-1855. 10.1089/ten.tea.2009.0531, 20067399.
11. Darling EM, Athanasiou KA. Retaining zonal chondrocyte phenotype by means of novel growth environments. Tissue Eng 2005, 11:395-403. 10.1089/ten.2005.11.395, 15871669.
12. Sharma A, Wood LD, Richardson JB, Roberts S, Kuiper NJ. Glycosaminoglycan profiles of repair tissue formed following autologous chondrocyte implantation differ from control cartilage. Arthritis Res Ther 2007, 9:R79. 10.1186/ar2278, 2206378, 17697352.
13. Klein TJ, Schumacher BL, Schmidt TA, Li KW, Voegtline MS, Masuda K, Thonar EJ, Sah RL. Tissue engineering of stratified articular cartilage from chondrocyte subpopulations. Osteoarthritis Cartilage 2003, 11:595-602. 10.1016/S1063-4584(03)00090-6, 12880582.
14. Gleghorn JP, Jones AR, Flannery CR, Bonassar LJ. Boundary mode frictional properties of engineered cartilaginous tissues. Eur Cell Mater 2007, 14:20-28.
15. McFarland R, Kaiser A. Draft Guidance for Industry: Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage. Rockville, MD, U.S: Department of Health and Human Services., http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/ucm072952.htm.
16. English A, Jones A, Corscadden D, Henshaw K, Chapman T, Emery P, McGonagle D. A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology (Oxford) 2007, 46:1676-1683.